XML 503 R41.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Components of Equity-Based Compensation
The following table sets forth the components of our stock-based compensation and expected tax benefit related to the plans in effect during the respective year:
Year Ended December 31,
202320222021
Stock-based compensation expense:
Restricted stock and restricted stock units (1)
$69.6 $53.7 $18.7 
Stock options13.8 9.9 3.0 
Incentive units (2)
— 2.4 11.6 
Total compensation expense$83.4 $66.0 $33.3 
Expected tax benefit:
Restricted stock and restricted stock units$6.8 $6.8 $3.4 
Stock options0.6 0.5 0.2 
Total compensation expense$7.4 $7.3 $3.6 
(1)Higher expense for restricted stock and restricted stock units in 2023 and 2022 compared to the respective prior year was primarily due to the additions of grants and the expense recognition associated with accelerated shares.
(2)Related to stock-based awards granted prior to the IPO.
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions
The following weighted average assumptions were used for options granted:

Year Ended December 31,
202320222021
Expected dividend yield (1)
N/A1.29 %N/A
Expected stock price volatility (2)
N/A33 %N/A
Risk-free interest rate (3)
N/A2.77 %N/A
Expected life of options (in years) (4)
N/A4.5N/A
Weighted average grant date fair valueN/A$5.42N/A
(1)For the 2022 grants, the expected dividend yield was based on our quarterly dividend divided by the three-month average stock price as of the grant date, annualized and continuously compounded.
(2)For 2022 grants, expected stock price volatility was calculated based 50% on D&B’s historical volatility and 50% on the leverage-adjusted volatility of our peer companies.
(3)Risk free interest rate was based on the term-matched, zero-coupon risk-free rate from the Treasury Constant Maturity yield curve, continuously compounded.
(4)For the 2022 grants, the expected term was based on the midpoint between the time of hurdle achievement and the expiration date.
Schedule of Stock Options, Restricted Stock and Restricted Stock Units Activity
The following table summarizes the stock options activity for the year ended December 31, 2023:

Stock options
Number of
options		Weighted-average
exercise price		Weighted average remaining contractual term (in years)Aggregate intrinsic value (in millions)
Balances, January 1, 2023
11,094,868 $19.296.8$—
Granted— $—
Forfeited(229,000)$18.56
Exercised— $—
Balances, December 31, 2023
10,865,868 $19.315.7$—
Expected to vest as of December 31, 2023
4,785,868 $15.898.5$—
Exercisable as of December 31, 2023
6,080,000 $22.003.5$—
The following table summarizes the restricted stock and restricted stock units activity for the year ended December 31, 2023:

Restricted stock and Restricted stock units
Number of
shares		Weighted-average
grant date
fair value		Weighted average remaining contractual term (in years)Aggregate intrinsic value
Balances, January 1, 2023
7,007,683 $17.281.2$85.9
Granted5,000,399 $11.27
Forfeited(603,594)$15.37
Vested(2,721,965)$17.59
Balances, December 31, 2023
8,682,523 $13.781.0$101.6
Schedule of Restricted Stock and Restricted Stock Units and Restricted Stock and Common Stock Activity
The following table summarizes information relating to the vesting of restricted stock and restricted stock units:

Year ended December 31,
2023
20222021
Fair value of shares vested$30.9 $15.8 $6.8 
Tax benefit realized upon vesting$3.7 $2.4 $0.9